Value of short-course antimicrobial therapy in community-acquired pneumonia

International Journal of Antimicrobial Agents

Volumn 26, Issue SUPPL. 3, 2005, Pages

  Blasi, Francesco ^a   Tarsia, Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Azithromycin microspheres; Community acquired pneumonia; Short course therapy

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM; CEFACLOR; CEFUROXIME AXETIL; CLARITHROMYCIN; CLAVULANIC ACID; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MICROSPHERE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN;

ABDOMINAL PAIN; ANTIMICROBIAL THERAPY; AREA UNDER THE CURVE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; DRUG TARGETING; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LOBAR PNEUMONIA; LOOSE FECES; MAXIMUM ALLOWABLE CONCENTRATION; MORBIDITY; MORTALITY; NAUSEA; NONHUMAN; OTITIS MEDIA; PALATABILITY; PATIENT COMPLIANCE; PEDIATRICS; PNEUMONIA; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; REVIEW; SEPTICEMIA; SHORT COURSE THERAPY; TASTE DISORDER; TREATMENT DURATION; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; URETHRITIS; UTERINE CERVICITIS; VENTILATOR ASSOCIATED PNEUMONIA; VOMITING;

EID: 33644913986     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(05)80321-8     Document Type: Article

References (36)

1. Vergis E.N., and Yu V.L. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host Semin Respir Infect 12 1997 322 328
2. Bartlett J.G., Dowell S.F., Mandel L.A., File T.M. Jr., Musher D.M., and Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults Clin Infect Dis 31 2000 347 382
3. Macfarlane J.T., Colville A., and Guion A. Prospective study of aetiology and outcome of adult lower respiratory-tract infections in the community Lancet 341 1993 511 514
4. Jokinen C., Heiskanen L., and Juvonen H. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland Am J Epidemiol 137 1993 977 988
5. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society Eur Respir J 11 1998 986 991
6. Niederman M.S., Mandell L.A., and Anzueto A. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 163 2001 1730 1754
7. Vegelin A.L., Bissumbhar P., and Joore J.C. Guidelines for severe community-acquired pneumonia in the western world Neth J Med 55 1999 110 117
8. Heffelfinger J.D., Dowell S.F., and Jorgensen J.H. Management of community acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-resistant Streptococcus pneumonia Therapeutic Working Group Arch Intern Med 160 2000 1399 1408
9. Matsushima T., and Japanese Respiratory Society The Japanese Respiratory Society Guidelines for management of community-acquired pneumonia in adults Nippon Rinsho 61 Suppl 2 2003 677 681
10. Mandell L.A., Marrie T.J., and Grossman R.F. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society Clin Infect Dis 31 2000 383 421
11. Mandell L.A., Bartlett J.G., and Dowell S.F. Update of practice guidelines for the management of community acquired pneumonia in immunocompetent adults Clin Infect Dis 37 2003 1405 1433
12. Available at: US Food and Drug Administration Labeling requirements for systemic antibacterial drug products intended for human use Accessed on June 20 2005
13. Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections J Antimicrob Chemother 49 2002 897 903
14. Reyes H., Guiscafre H., and Munoz O. Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea J Clin Epidemiol 50 1997 1297 1304
15. Rahav G., Fidel J., and Gibor Y. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia Int J Antimicrob Agents 24 2004 181 184
16. Dunbar L.M., Wunderink R.G., and Habib M.P. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm Clin Infect Dis 37 2003 752 760
17. Schrag S.J., Peña C., and Fernandez J. Effect of short course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial J Am Med Assoc 286 2001 49 56
18. Chastre J., Wolff M., and Fagon J.Y. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial J Am Med Assoc 290 2003 2588 2598
19. Stahl J.E., Barza M.D., and Desfardin J. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia Arch Intern Med 159 1999 2576 2580
20. Martinez J.A., Horcajada J.P., and Almela M. Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia Clin Infect Dis 36 2003 389 395
21. Gleason P.P., Meehan T.P., and Fine J.M. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia Arch Intern Med 159 1999 2562 2572
22. Brown R.B., Iannini P., and Gross P. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database Chest 123 2003 1503 1511
23. Trowbridge J.F., Artymowicz R.J., and Lee C.E. Antimicrobial selection and length of hospital stay in patients with community-acquired pneumonia J Clin Outcomes Management 9 2002 613 619
24. Macfarlane J. Severe pneumonia and a second antibiotic Lancet 359 2002 1170 1172
25. Kauppinen M., and Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment Clin Infect Dis 21 1995 5244 5252
26. Lieberman D., Ben-Yaakov M., and Lazarovich Z. Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients Infection 24 1996 109 114
27. Drehobl M.A., De Salvo M.C., Lewis D.E., and Breen J.D. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults Chest 128 2005 2230 2237
28. D'Ignazio J., Camere M.A., Lewis D.E., Jorgensen D., and Breen J.D. Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community acquired pneumonia in adults Antimicrob Agents Chemother 49 2005 4035 4041
29. Schentag J.J., and Ballow C.H. Tissue-directed pharmacokinetics Am J Med 91 Suppl 3A 1991 5S 11S
30. Rothermel C.D. Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale Curr Ther Res 64 Suppl 1 2003 4 15
31. Abstract A-57 Girard D., Finegan S.M., Cimochowski C.R., Dunne M.W., and Giovanis A. Accelerated dosing of azithromycin in preclinical infection models Poster presented at the 102nd American Society for Microbiology General Meeting Salt Lake City, UT, May 19-23 2002
32. Abstract B-1181 Kamicker B.J., Bertsche C.D., and Medina I.A. In rodent models, single dose of azithromycin was more effective than dosing split over 3 or 5 days Abstracts of the 44th Annual Meeting of ICAAC 2004
33. Handsfield H.H., Dalu Z.A., and Martin D.H. Multicenter trial of singledose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group Sex Transm Dis 21 1994 107 111
34. Craig W.A. Postantibiotic effects and the dosing of macrolides, azalides, and streptogramins Zinner S.H. Young L.S. Acar J.F. Neu H.C. Expanding Indications for the New Macrolides, Azalides and Streptogramins 1997 Marcel Dekker New York 27 38
35. File T.M. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia Clin Infect Dis 39 2004 5159 5164
36. Pichichero M.E. Short course antibiotic therapy for respiratory infections: a review of the evidence Pediatr Infect Dis J 19 2000 929 937